Keratinocyte apoptosis was present in clinically intact skin in a patient treated with enfortumab vedotin.

Competing Interests: Conflict of interest statement The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: H.N. has received speaker's fees from Astellas pharma. All remaining authors have declared no conflicts of interest.